MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results

Executive Summary

• MediPharm Labs Corp. will publish its third‑quarter financial results for the three and nine months ended September 30, 2025 on Thursday, November 13, 2025 before market open.
• An investor conference call and webcast will be held at 10:00 a.m. ET on the same day to discuss the results.
• The release includes standard forward‑looking statements regarding future regulatory approvals and financing.

Key Details

• Results Release Date: Thursday, November 13, 2025 (pre‑market).
• Coverage Period: Q3 2025 – three months ended September 30, 2025; nine months ended September 30, 2025.
• Conference Call:
• Time: 10:00 a.m. Eastern Time, November 13, 2025
• Toll‑Free (North America): (888) 330‑2454
• International Toll: +1 (240) 789‑2714
• Conference ID: 4921762
• Webcast: Live streaming link provided in the release; replay available at https://www.medipharmlabs.com/investors one day after the call.
• Purpose: Discuss financial performance, operational updates, and outlook for the remainder of 2025 and beyond.
• Forward‑Looking Statements: The release contains customary forward‑looking language covering expectations about regulatory approvals (e.g., U.S. FDA registration), financing needs, and other business risks.

Notable Quotes

(No direct quotes from executives were included in the release.)